CINECA IRIS Institutional Research Information System

- PSMA can be overexpressed in thymic tumours; - PSMA PET/CT is a whole-body procedure and pitfalls and variants are frequently described in literature; - Radioligand therapies represent a new alternative treatment in advanced prostate cancer patients. Their use in other malignancies could be considered in the near future, if high PSMA expression in those tumours is confirmed

Incidental detection of basaloid thymic carcinoma with 68 Ga-PSMA-11 PET/CT in recurrent prostate cancer patient

Ceci, F.
;
2018-01-01

Abstract

- PSMA can be overexpressed in thymic tumours; - PSMA PET/CT is a whole-body procedure and pitfalls and variants are frequently described in literature; - Radioligand therapies represent a new alternative treatment in advanced prostate cancer patients. Their use in other malignancies could be considered in the near future, if high PSMA expression in those tumours is confirmed
2018
n/a
N/A
N/A
PSMA; PET/CT: prostate cancer; thymic cancer
Farolfi, A.; Ceci, F.; Graziani, T.; Lambertini, A.; CERVATI, VERONICA; Basilico, G. L.; Biraghi, T.; Briganti, A.; Castellucci, P.; Fanti, S....espandi
03A-Articolo su Rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/1726044
Citazioni
  • ???jsp.display-item.citation.pmc??? 3
  • Scopus 4
  • ???jsp.display-item.citation.isi??? 3
social impact